Literature DB >> 27265126

MicroRNA hsa-miR-4674 in Hemolysis-Free Blood Plasma Is Associated with Distant Metastases of Prostatic Cancer.

E N Knyazev1, T R Samatov1, K A Fomicheva2, K M Nyushko2, B Ya Alekseev2, M Yu Shkurnikov3,4.   

Abstract

We analyzed microRNA profile in hemolysis-free blood plasma of patients with prostatic cancer. The metastatic form of prostatic cancer was found to be associated with increased levels of hsa-miR-22-3p, hsa-miR-663a, and hsa-miR-4674 in comparison with non-metastatic form. Common candidate target genes of these microRNA include JUNB, KMT2A, and XPO6.

Entities:  

Keywords:  blood plasma; metastases; microRNA; microarray analysis; prostatic cancer

Mesh：

Substances：

Year:  2016        PMID： 27265126     DOI： 10.1007/s10517-016-3358-6

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN： 0007-4888            Impact factor:   0.804


  15 in total

1.  MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer's disease.

Authors:  Subodh Kumar; Murali Vijayan; P Hemachandra Reddy
Journal:  Hum Mol Genet       Date:  2017-10-01       Impact factor: 6.150

Review 2.  Karyopherins in cancer.

Authors:  Tolga Çağatay; Yuh Min Chook
Journal:  Curr Opin Cell Biol       Date:  2018-02-04       Impact factor: 8.382

3.  Tumor cell-secreted exosomal miR-22-3p inhibits transgelin and induces vascular abnormalization to promote tumor budding.

Authors:  Yaju Feng; Lumeng Wang; Ting Wang; Ying Li; Qingqing Xun; Renya Zhang; Lin Liu; Lei Li; Wei Wang; Yixuan Tian; Lili Yang; Xiao Zhi; Bijiao Zhou; Xin Chen; Tao Sun; Yanrong Liu
Journal:  Mol Ther       Date:  2021-02-10       Impact factor: 12.910

Review 4.  Molecular mechanisms and clinical applications of miR-22 in regulating malignant progression in human cancer (Review).

Authors:  Jingyu Wang; Yuan Li; Meiman Ding; Honghe Zhang; Xiaoming Xu; Jinlong Tang
Journal:  Int J Oncol       Date:  2016-12-19       Impact factor: 5.650

5.  A mathematical model as a tool to identify microRNAs with highest impact on transcriptome changes.

Authors:  Marzena Mura; Roman Jaksik; Anna Lalik; Krzysztof Biernacki; Marek Kimmel; Joanna Rzeszowska-Wolny; Krzysztof Fujarewicz
Journal:  BMC Genomics       Date:  2019-02-06       Impact factor: 3.969

6.  Deep Sequencing of Small RNAs from Neurosurgical Extracellular Vesicles Substantiates miR-486-3p as a Circulating Biomarker that Distinguishes Glioblastoma from Lower-Grade Astrocytoma Patients.

Authors:  Susannah Hallal; Saeideh Ebrahim Khani; Heng Wei; Maggie Yuk Ting Lee; Hao-Wen Sim; Joanne Sy; Brindha Shivalingam; Michael E Buckland; Kimberley L Alexander-Kaufman
Journal:  Int J Mol Sci       Date:  2020-07-13       Impact factor: 5.923

7.  MiR-22-3p Regulates Cell Proliferation and Inhibits Cell Apoptosis through Targeting the eIF4EBP3 Gene in Human Cervical Squamous Carcinoma Cells.

Authors:  Kang-Tai Lv; Zhu Liu; Jie Feng; Wei Zhao; Tao Hao; Wen-Yan Ding; Jing-Ping Chu; Ling-Juan Gao
Journal:  Int J Med Sci       Date:  2018-01-01       Impact factor: 3.738

8.  miRNA Reference Genes in Extracellular Vesicles Released from Amniotic Membrane-Derived Mesenchymal Stromal Cells.

Authors:  Enrico Ragni; Carlotta Perucca Orfei; Antonietta Rosa Silini; Alessandra Colombini; Marco Viganò; Ornella Parolini; Laura de Girolamo
Journal:  Pharmaceutics       Date:  2020-04-11       Impact factor: 6.321

9.  MicroRNA-194 regulates cell viability and apoptosis by targeting CDH2 in prostatic cancer.

Authors:  Song Gao; Zhiying Zhao; Rong Wu; Lina Wu; Xin Tian; Zhenyong Zhang
Journal:  Onco Targets Ther       Date:  2018-08-14       Impact factor: 4.147

10.  miR-663a inhibits tumor growth and invasion by regulating TGF-β1 in hepatocellular carcinoma.

Authors:  Chengshuo Zhang; Baomin Chen; Ao Jiao; Feng Li; Ning Sun; Guoqing Zhang; Jialin Zhang
Journal:  BMC Cancer       Date:  2018-11-28       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.